Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck: Long-term results including functional outcome

Strahlentherapie und Onkologie

Volumn 174, Issue 8, 1998, Pages 397-402

  Huguenin, Pia ^a   Glanzmann, Christoph ^a   Taussky, Daniel ^a   Lütolf, Urs Martin ^a   Schmid, Stephan ^a   Moe, Kris ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chemotherapy; Head and neck; Quality of life; Radiotherapy

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031815803     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03038560     Document Type: Article

References (22)

1. Aaronson NK, Ahmedzai S, Bergman B, et al. QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
2. Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality-of-life assessments in head and neck cancer patients. Acta Oncol 1994;3:879-85.
3. Bjordal K, Freng A, Thorvik J, et al. Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Eur J Cancer 1995;31B:235-41.
4. Choi KN, Rotman M, Aziz H, et al. Locally advanced paranasal sinus and nasopharynx tumors treated with hyperfractionated radiation and concomitant infusion of cisplatin. Cancer 1991;67:2748-52.
5. Cooper KN, Rotman M, Aziz H, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17:449-56.
6. Dühmke E, Geibel T, Golms G, et al. Combined modality treatment of advanced head and neck cancer using low-dose cisplatinum and accelerated fractionation. Strahlenther Onkol 1988;164:11-6.
7. Glanzmann C, Lütolf UM. Follow-up data of our pilot study on concomitant hyperfractionated radiotherapy and cisplatinum (CDDP) in patients with advanced cancer of the head and neck. Strahlenther Onkol 1992;168:453-6.
8. Harrison LB, Pfister DG, Fass DE, et al. Concomitant chemotherapy and radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 1991;21:703-8.
9. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotrtinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
10. Horiot JC, Le Fur R, N'Guyen TN, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
11. Marcial VA, Pajak TF, Mohuddin M, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous-cell carcinomas of the head and neck. Cancer 1990;66:1861-8.
12. Mendenhall WM, Parsons JT. Letter to the editor. N Engl J Med 1993;328-579-80.
13. Merlano M, Benasso M, Corvò R, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous-cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88:583-9.
14. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992;327:1115-21.
15. Munro AJ. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
16. Parsons JT. Time-dose-volume relations in radiation therapy. In Million RR, Cassisi NJ (Eds) Management of head and neck cancer. Philadelphia: Lippincott, 1994:203-43.
17. Pinto LHJ, Canary PCV, Araucho CMM, et al. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:557-62.
18. Seegenschmiedt MH, Sauer R. Systematik der akuten und chronischen Strahlenfolgen. Strahlenther Onkol 1993;169:83-95.
19. Stell PM, Rawson NSB. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990;61:779-87.
20. Vokes E E, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-34.
21. Vokes EE, Weichselbaum RR. Radiotherapy with concomitant chemotherapy for head and neck cancer. Haematol Oncol Clin North Am 1991;5:753-67.
22. Wendt TG. Radiochemotherapie bei fortgeschrittenen Kopf-Hals-Tumoren - was ist gesichert? Strahlenther Onkol 1996;172:409-16.